Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

OPTIMAL Motor Learning in Table Tennis: A fNIRS Study

27 de outubro de 2026 atualizado por: Hui-Ting Shih, National Yang Ming Chiao Tung University

Does the OPTIMAL Theory Enhance Motor Learning and Cognitive and Sensorimotor Area Cortical Activation? A Theoretical Mechanism Validation in Young, Older Adults, and Cognitively Impaired Older Adults Novice Table Tennis Players

This study investigates how OPTIMAL theory influences table tennis backhand learning in young, healthy older, and mild cognitively impaired older adults. Meanwhile, we investigate the neural mechanisms of motor skill acquisition across different ages. This study utilizes functional near-infrared spectroscopy (fNIRS) to monitor brain activity. Beyond immediate performance, the research focuses on Retention (sustained skill over time) and Transfer (application to novel tasks) as critical indicators of true motor learning. To ensure objective results, a double-blind design is employed, where both participants and data analysts remain blinded to group assignments during behavioral and fNIRS data processing to minimize bias.

Visão geral do estudo

Tipo de estudo

Intervencional

Inscrição (Estimado)

90

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

Locais de estudo

      • Taipei, Taiwan
        • National Yang Ming Chiao Tung University
        • Contato:

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

18 anos a 80 anos (Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

Sim

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Healthy young adults are aged between 18 and 30 years, while healthy older adults and older adults with mild cognitive impairment (MCI) are aged between 65 and 80 years. Regarding cognitive criteria, healthy young adults and healthy older adults must score 24 or higher on the Mini-Mental State Examination (MMSE). Older adults with MCI must further meet the following diagnostic criteria for MCI:

  1. Subjective cognitive decline: The participants themselves or their family members/primary caregivers report a decline in memory or cognitive function.
  2. Objective cognitive impairment: The education-adjusted score on the Taiwanese version of the Montreal Cognitive Assessment (MoCA-T) is between 20 and 23. One point is added to the total MoCA-T score for individuals with less than 12 years of education. Considering the heterogeneity in education levels among Taiwan's older generation, if a participant has 6 or fewer years of education (elementary school or below) or is illiterate, the Chinese version of the Montreal Cognitive Assessment Basic (MoCA-B) will be administered as a supplement. This is to reduce false-positive interference on the visuospatial and executive function subtests caused by a low educational level.
  3. Preserved activities of daily living: The score on the Compensatory Instrumental Activities of Daily Living (IADL-C) scale ranges from 1.34 to 3.06, indicating that the participant possesses the ability to live independently and has not reached the level of dementia.

In addition to the age and cognitive requirements, participants across all three groups must meet the following inclusion criteria:

  1. Right-handed, with an Edinburgh Handedness Inventory (EHI) score > 40;
  2. Table tennis beginners who have never received professional table tennis instruction;
  3. Played table tennis less than once a month in the past year;
  4. Normal hearing and normal or corrected-to-normal vision.

Exclusion criteria include:

  1. Over 3 years of experience in other racket sports;
  2. A history of neurological or psychiatric disorders;
  3. Any musculoskeletal system diseases that might interfere with the experiment;
  4. Unstable cardiopulmonary function rendering them unsuitable for moderate-intensity aerobic exercise;
  5. Taking medications that affect the central nervous system or blood oxygen signals, such as potent sedative-hypnotics, antiepileptic drugs, or antipsychotic medications.

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Ciência básica
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Dobro

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Young Adults - OPTIMAL

OPTIMAL theory-based instruction

Dose: 15 blocks of practice, with each block consisting of 30 table tennis backhand strokes (Total: 450 trials).

Description: The intervention integrates three components: (1) Autonomy Support (AS): Participants choose the color of the table tennis balls. (2) Enhanced Expectancy (EE): A visual illusion is used where the target is surrounded by smaller circles, making the target appear larger to boost confidence. (3) External Focus (EF): Instructions direct attention toward the target rather than limb movements.

Comparador Ativo: Young Adults - Control

Conventional instruction

Dose: Same as Experimental group (15 blocks x 30 trials; Total: 450 trials).

Description: (1) No choice is provided (Yoked control). (2) A visual illusion is used where the target is surrounded by larger circles, making the target appear smaller. (3) Instructions focus on body mechanics, such as elbow position and swing path (Internal Focus).

Experimental: Older Adults - OPTIMAL

OPTIMAL theory-based instruction

Dose: 15 blocks of practice, with each block consisting of 30 table tennis backhand strokes (Total: 450 trials).

Description: The intervention integrates three components: (1) Autonomy Support (AS): Participants choose the color of the table tennis balls. (2) Enhanced Expectancy (EE): A visual illusion is used where the target is surrounded by smaller circles, making the target appear larger to boost confidence. (3) External Focus (EF): Instructions direct attention toward the target rather than limb movements.

Comparador Ativo: Older Adults - Control

Conventional instruction

Dose: Same as Experimental group (15 blocks x 30 trials; Total: 450 trials).

Description: (1) No choice is provided (Yoked control). (2) A visual illusion is used where the target is surrounded by larger circles, making the target appear smaller. (3) Instructions focus on body mechanics, such as elbow position and swing path (Internal Focus).

Experimental: MCI Older Adults - OPTIMAL

OPTIMAL theory-based instruction

Dose: 15 blocks of practice, with each block consisting of 30 table tennis backhand strokes (Total: 450 trials).

Description: The intervention integrates three components: (1) Autonomy Support (AS): Participants choose the color of the table tennis balls. (2) Enhanced Expectancy (EE): A visual illusion is used where the target is surrounded by smaller circles, making the target appear larger to boost confidence. (3) External Focus (EF): Instructions direct attention toward the target rather than limb movements.

Comparador Ativo: MCI Older Adults - Control

Conventional instruction

Dose: Same as Experimental group (15 blocks x 30 trials; Total: 450 trials).

Description: (1) No choice is provided (Yoked control). (2) A visual illusion is used where the target is surrounded by larger circles, making the target appear smaller. (3) Instructions focus on body mechanics, such as elbow position and swing path (Internal Focus).

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Motor Performance (Accuracy Score)
Prazo: Day 1 Pre-test: before practice (3 blocks) Acquisition: during practice (15 blocks) Post-test: immediately after practice (3 blocks) Day 2 Retention test: at least 24 hours after Day 1 (3 blocks) Transfer test: at least 24 hours after Day 1 (3 blocks)

Accuracy is measured with a target-centered scoring system on a 0-7 scale per ball; higher scores indicate better accuracy.

7 pts: Hit target (10 cm diameter).

6 pts: Hit zone (20 cm).

5 pts: Hit zone (30 cm).

4 pts: Hit zone (40 cm).

3 pts: Hit zone (50 cm).

2 pts: Hit opposite table surface but missed target zones.

1 pt: Ball was hit but missed the opposite table.

0 pts: Failed to hit the ball.

The performance is presented by blocks. Each block contains 30 balls. The average score of each block is calculated.

Day 1 Pre-test: before practice (3 blocks) Acquisition: during practice (15 blocks) Post-test: immediately after practice (3 blocks) Day 2 Retention test: at least 24 hours after Day 1 (3 blocks) Transfer test: at least 24 hours after Day 1 (3 blocks)

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Prefrontal Cortex (DLPFC) Activation
Prazo: Day 1 Pre-test: before practice (3 blocks) Acquisition: during practice (15 blocks) Post-test: immediately after practice (3 blocks) Day 2 Retention test: at least 24 hours after Day 1 (3 blocks) Transfer test: at least 24 hours after Day 1 (3 blocks)

Change in oxygenated hemoglobin (HbO) concentration (μM) in the bilateral dorsolateral prefrontal cortex (DLPFC), measured using functional near-infrared spectroscopy (fNIRS) during table tennis backhand task blocks.

Day 1 Pre-test: before practice (3 blocks) Acquisition: during practice (15 blocks) Post-test: immediately after practice (3 blocks) Day 2 Retention test: at least 24 hours after Day 1 (3 blocks) Transfer test: at least 24 hours after Day 1 (3 blocks)
Premotor Cortex (PMC) Activation
Prazo: Day 1 Pre-test: before practice (3 blocks) Acquisition: during practice (15 blocks) Post-test: immediately after practice (3 blocks) Day 2 Retention test: at least 24 hours after Day 1 (3 blocks) Transfer test: at least 24 hours after Day 1 (3 blocks)

Change in oxygenated hemoglobin (HbO) concentration (μM) in the bilateral premotor cortex (PMC), measured using functional near-infrared spectroscopy (fNIRS) during table tennis backhand task blocks.

Day 1 Pre-test: before practice (3 blocks) Acquisition: during practice (15 blocks) Post-test: immediately after practice (3 blocks) Day 2 Retention test: at least 24 hours after Day 1 (3 blocks) Transfer test: at least 24 hours after Day 1 (3 blocks)
Supplementary Motor Area (SMA) Activation
Prazo: Day 1 Pre-test: before practice (3 blocks) Acquisition: during practice (15 blocks) Post-test: immediately after practice (3 blocks) Day 2 Retention test: at least 24 hours after Day 1 (3 blocks) Transfer test: at least 24 hours after Day 1 (3 blocks)

Change in oxygenated hemoglobin (HbO) concentration (μM) in the supplementary motor area (SMA), measured using functional near-infrared spectroscopy (fNIRS) during table tennis backhand task blocks.

Day 1 Pre-test: before practice (3 blocks) Acquisition: during practice (15 blocks) Post-test: immediately after practice (3 blocks) Day 2 Retention test: at least 24 hours after Day 1 (3 blocks) Transfer test: at least 24 hours after Day 1 (3 blocks)
Sensorimotor Cortex (SMC) Activation
Prazo: Day 1 Pre-test: before practice (3 blocks) Acquisition: during practice (15 blocks) Post-test: immediately after practice (3 blocks) Day 2 Retention test: at least 24 hours after Day 1 (3 blocks) Transfer test: at least 24 hours after Day 1 (3 blocks)

Change in oxygenated hemoglobin (HbO) concentration (μM) in the sensorimotor cortex (SMC), measured using functional near-infrared spectroscopy (fNIRS) during table tennis backhand task blocks.

Day 1 Pre-test: before practice (3 blocks) Acquisition: during practice (15 blocks) Post-test: immediately after practice (3 blocks) Day 2 Retention test: at least 24 hours after Day 1 (3 blocks) Transfer test: at least 24 hours after Day 1 (3 blocks)
Self-Efficacy (General Self-Efficacy Scale, GSES)
Prazo: Day 1 Immediately after Pre-test

Self-efficacy is measured with the General Self-Efficacy Scale (GSES), a 10-item self-report scale.

Each item is rated from 1 (not at all true) to 4 (exactly true), giving a total score of 10 to 40; higher scores indicate higher self-efficacy.

Day 1 Immediately after Pre-test

Outras medidas de resultado

Medida de resultado
Descrição da medida
Prazo
Manipulation Check
Prazo: Day 1 After Post-test Day 2 After Transfer test

A questionnaire verifying whether participants perceived the assigned experimental manipulations (autonomy support, enhanced expectancies, and attentional focus). It consists of 19 items rated mainly on 0-10 scales (items 10-11 on a 0-100% scale); higher scores indicate stronger agreement or greater perception of the corresponding construct.

Day 1 After Post-test Day 2 After Transfer test

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Estimado)

1 de novembro de 2026

Conclusão Primária (Estimado)

31 de agosto de 2028

Conclusão do estudo (Estimado)

31 de outubro de 2028

Datas de inscrição no estudo

Enviado pela primeira vez

8 de outubro de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

27 de outubro de 2026

Primeira postagem (Real)

3 de novembro de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

3 de novembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

27 de outubro de 2026

Última verificação

1 de outubro de 2026

Mais Informações

Termos relacionados a este estudo

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever